PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO

42/2000
19 Oct/oct 2000 PCT Gazette - Section I - Gazette du PCT 15167
(74) FRITZ, Joachim, T. et al. / etc.; Borden
Ladner Gervais LLP, 1000–60 Queen Street,
Ottawa, Ontario K1P 5Y7 (CA).
(81) AU CA JP NZ; EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE).
(51) 7 A61K 39/39, 48/00, 9/00, A61P 35/00,
31/00, 33/00
(11) WO 00/61184
(21) PCT/US00/08714
(13) A2
(22) 10 Apr/avr 2000 (10.04.2000)
(25) en (26) en
(30) 60/128,370 8 Apr/avr 1999
(08.04.1999)
US
(30) 09/545,417 7 Apr/avr 2000
(07.04.2000)
US
(43) 19 Oct/oct 2000 (19.10.2000)
(54) DRY FORMULATION FOR TRANSCU-
TANEOUS IMMUNIZATION
FORMULATION SECHE POUR IMMU-
NISATION TRANSCUTANEE
(63) US 09/545,417 (CON)
7 Apr/avr 2000 (07.04.2000)
(71, 72) GLENN, Gregory, M. [US/US]; 8010
Riverside Drive, Cabin John, MD 20818
(US). SCHARTON–KERSTEN, Tanya
[US/US]; 6009 Benaldev Drive, Bethesda,
MD 20816 (US).
(74) KOKULIS, Paul, N. et al. / etc.; Pillsbury
Madison & Sutro LLP, 1100 New York
Avenue, N.W., Washington, DC 20005 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY CA CH CN CR CU CZ DE DK DM DZ
EE ES FI GB GD GE GH GM HR HU ID
IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ
VN YU ZA ZW; AP (GH GM KE LS MW
SD SL SZ TZ UG ZW); EA (AM AZ BY
KG KZ MD RU TJ TM); EP (AT BE CH
CY DE DK ES FI FR GB GR IE IT LU MC
NL PT SE); OA (BF BJ CF CG CI CM GA
GN GW ML MR NE SN TD TG).
(51) 7 A61K 39/395 // (A61K 39/395, 31:335)
(11) WO 00/61185
(21) PCT/US00/09247
(13) A1
(22) 7 Apr/avr 2000 (07.04.2000)
(25) en (26) en
(30) 60/128,564 9 Apr/avr 1999
(09.04.1999)
US
(43) 19 Oct/oct 2000 (19.10.2000)
(54) DOCETAXEL IN COMBINATION
WITH RHUMAB HER2 FOR THE
TREATMENT OF CANCERS
UTILISATION DE DOCETAXEL COM-
BINE A RHUMAB HER2 POUR LE
TRAITEMENT DE CANCERS
(71, 72) VOGEL, Charles, L. [–/US]; Fort Lauderdale,
FL (US). BELLET, Robert, E. [–
/US]; Elkins Park, PA (US).
(74) CHAPMAN, Ernest, F. et al. / etc.; Finnegan,
Henderson, Farabow, Garrett & Dunner,
LLP, 1300 I Street, N.W., Washington, DC
20005–3315 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY CA CH CN CR CU CZ DE DK DM DZ
EE ES FI GB GD GE GH GM HR HU ID
IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG UZ VN
YU ZA ZW; AP (GH GM KE LS MW SD
SL SZ TZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY
DE DK ES FI FR GB GR IE IT LU MC NL
PT SE); OA (BF BJ CF CG CI CM GA GN
GW ML MR NE SN TD TG).
Published / Publiée :(c)
(51) 7 A61K 39/395, C07K 16/00
(11) WO 00/61186 (13) A1
(21) PCT/US00/09255
(22) 7 Apr/avr 2000 (07.04.2000)
(25) en (26) en
(30) 60/128,713 8 Apr/avr 1999
(08.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US
(54) USE OF ANTI–VEGF ANTIBODY TO
ENHANCE RADIATION IN CANCER
THERAPY
UTILISATION D’ANTICORPS ANTI–
VEGF POUR ACCENTUER LE
RAYONNEMENT LORS D’UNE THE-
RAPIE ANTICANCEREUSE
(71, 72) WEICHSELBAUM, Ralph, R.
[US/US]; 1909 North Building, Chicago, IL
60614 (US).
(72) KUFE, Donald, W.; 179 Grove Street,
Wellesley, MA 02181 (US).
(74) CLARK, Paul, T.; Clark & Elbing, LLP,
176 Federal Street, Boston, MA 02110–2214
(US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY CA CH CN CR CU CZ DE DK DM DZ
EE ES FI GB GD GE GH GM HR HU ID
IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG UZ VN
YU ZA ZW; AP (GH GM KE LS MW SD
SL SZ TZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY
DE DK ES FI FR GB GR IE IT LU MC NL
PT SE); OA (BF BJ CF CG CI CM GA GN
GW ML MR NE SN TD TG).
Published / Publiée :(c)
(51) 7 A61K 41/00, 31/4745, A61P 35/00
(11) WO 00/61187 (13) A1
(21) PCT/US00/07734
(22) 24 Mar/mar 2000 (24.03.2000)
(25) en (26) en
(30) 09/290,446 13 Apr/avr 1999
(13.04.1999)
US
(43) 19 Oct/oct 2000 (19.10.2000)
(54) RADIOENHANCED CANCER TREAT-
MENT USING ORALLY ADMINISTE-
RED CAMPTOTHECIN DERIVATIVES
ADMINISTRATION PAR VOIE ORALE
DE DERIVES DE CAMPTOTHECINE
POUVANT AMELIORER L’EFFET
THERAPEUTIQUE DES RADIATIONS
DANS LE TRAITEMENT CONTRE LE
CANCER
(63) US 09/290,446 (CON)
13 Apr/avr 1999 (13.04.1999)
(71) SUPERGEN, INC. [US/US]; Two Annabel
Lane, Suite 220, San Ramon, CA 94583
(US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) CHOY, Hak [US/US]; Department of
Radiation and Oncology, The Vanderbilt Clinic,
Room V902, 1301 22nd Avenue South,
Nashville, TN 37232 (US). LENAZ, Luigi
[US/US]; 11 Planetree Court, Newtown, PA
18940 (US).
(74) WEITZ, David, J.; Wilson Sonsini Goodrich
& Rosati, 650 Page Mill Road, Palo
Alto, CA 94304–1050 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY CA CH CN CR CU CZ DE DK DM DZ
EE ES FI GB GD GE GH GM HR HU ID
IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ
VN YU ZA ZW; AP (GH GM KE LS MW
SD SL SZ TZ UG ZW); EA (AM AZ BY
KG KZ MD RU TJ TM); EP (AT BE CH
CY DE DK ES FI FR GB GR IE IT LU MC
NL PT SE); OA (BF BJ CF CG CI CM GA
GN GW ML MR NE SN TD TG).
Published / Publiée :(c)
(51) 7 A61K 45/06, 31/55, 31/53, 31/195, A61P
29/00
(11) WO 00/61188 (13) A1
(21) PCT/US00/09387
(22) 10 Apr/avr 2000 (10.04.2000)
(25) en (26) en
(30) 60/128,543 9 Apr/avr 1999
(09.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US
(54) SODIUM CHANNEL BLOCKER
COMPOSITIONS
THEREOF
AND THE USE
COMPOSITION DE BLOCAGE DU CA-
NAL SODIQUE ET LEUR UTILISA-
TION
(71) COCENSYS, INC. [US/US]; 213
Technology Drive, Irvine, CA 92618 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(71, 72) LAN, Nancy, C. [US/US]; 522 Hermosa
Street, South Pasadena, CA 91030 (US).
(74) COVERT, John, M. et al. / etc.; Sterne,
Kessler, Goldstein & Fox P.L.L.C., Suite
600, 1100 New York Avenue, N.W., Washington,
DC 20005–3934 (US).